ZTS.NYSEZoetis INC

Form 4: Zoetis Executive Rimma Driscoll Reports Acquisition of Phantom Stock Units

Sentiment:

SEC Form 4 Filing


Executive Vice President Rimma Driscoll reports acquisition of phantom stock units in Zoetis Inc. through the company's Supplemental Savings Plan.

Summary

  • On March 28, 2024, Rimma Driscoll, an Executive Vice President at Zoetis Inc., acquired phantom stock units pursuant to the Zoetis Supplemental Savings Plan.
  • The transaction involved the acquisition of 170.5454 phantom stock units at a price of $54.33 per unit.
  • Following the transaction, Driscoll directly owns 4,253.0281 phantom stock units.
  • These phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
  • Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit).

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation transaction, which is generally viewed neutrally. The acquisition of phantom stock units suggests confidence in the company's future performance, contributing to a slightly positive sentiment.

Positives

  • The acquisition of phantom stock units aligns the executive's interests with the company's performance.
  • The Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's success.

Industry Context

Executive compensation packages often include stock-based awards to incentivize performance and align executive interests with shareholder value. Phantom stock units are a common tool used for this purpose, particularly in companies with established equity compensation plans.

Comparison to Industry Standards

  • Zoetis's use of phantom stock units in its executive compensation package is consistent with industry practices among large pharmaceutical and animal health companies.
  • Companies like Elanco and Merck Animal Health also utilize similar equity-based compensation methods to incentivize their executives.
  • The specific terms and conditions of the phantom stock units, such as vesting schedules and settlement terms, would need to be compared to those offered by peer companies to fully assess the competitiveness of Zoetis's compensation package.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns executive compensation with company performance.
  • Employees may view the Supplemental Savings Plan as a positive benefit.

Key Dates

DateDescription
03/28/2024Date of transaction: Acquisition of phantom stock units
04/01/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.